Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...

New technologies and care plans aim to enhance treatment options for patients in Mitchell and the surrounding area ...

Chronic low back pain can disrupt your daily life, keeping you from enjoying family moments, outdoor adventures or even ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non ...

Women's pain is often misdiagnosed or ignored. But what's being done about it? We asked women and MDs to weigh in on.

The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...

In multidisciplinary guidelines issued by the American Society of Regional Anesthesia and Pain Medicine and publishe ...